A carregar...
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is a predominantly pediatric soft-tissue cancer where the tumor cells exhibit characteristics of the developing skeletal muscle, and the two most common sub-types are embryonal and alveolar RMS. Elevated activation of the receptor tyrosine kinase (RTK) MET is frequent in RMS a...
Na minha lista:
| Publicado no: | Cell Death Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833614/ https://ncbi.nlm.nih.gov/pubmed/29445192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0261-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|